Centre Hospitalier Saint-Joseph Saint-Luc
Lyon 69365
2 studies enrolling now · 6 studies all time
What they study most
Acute Myocardial Infarction (AMI), Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Cardiovascular Risk, Chronic Kidney Disease, Elevated Lp(a), Heart Failure, Heart Failure With Preserved Ejection Fraction, Obesity, Overweight, Transthyretin Amyloid Cardiomyopathy
Studies at this site
- Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
- ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
- A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
- Levels of Inflammation in People With Cardiovascular Disease (POSEIDON) — Completed
- Global Prevalence of ATTR-CM in Participants With HFpEF — Stopped early